A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT04910568 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04910568
- Sponsor
- Genentech, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-26
- Primary completion
- 2028-12-21
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.